The analyses of concurrent and mutually exclusive mutations among the overall gene mutations in the TCGA‐BLCA patients found that TP53 had concurrent mutations with RB1 and MUC16, and had mutually exclusive mutations with FGFR3, ATM and other genes (Figure 3C). This evidence concerns the gene FGFR3 and bladder transitional cell carcinoma.